BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6344632)

  • 41. Relation of bone marrow findings to serum protein changes in lymphosarcoma, chronic lymphocytic leukemia and Hodgkin's disease.
    ONAT A; COOPER T
    Blood; 1960 Jan; 15():114-29. PubMed ID: 14428869
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ABNORMAL KARYOTYPE FINDINGS IN BONE MARROW AND LYMPH NODE ASPIRATES OF A PATIENT WITH MALIGNANT LYMPHOMA.
    TJIO JH; MARSH JC; WHANG J; FREI F
    Blood; 1963 Aug; 22():178-90. PubMed ID: 14045302
    [No Abstract]   [Full Text] [Related]  

  • 44. Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma.
    Kung PC; Long JC; McCaffrey RP; Ratliff RL; Harrison TA; Baltimore D
    Am J Med; 1978 May; 64(5):788-94. PubMed ID: 347933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal antibody SN10 which shows a highly selective reactivity with human B leukemia-lymphoma and is effectively internalized into cells.
    Takeuchi T; Barcos MP; Seon BK
    Cancer Res; 1991 Jun; 51(11):2985-93. PubMed ID: 1709587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymphocytic lymphoma simulating hairy cell leukemia: a consideration of reliable and unreliable diagnostic features.
    Palutke M; Tabaczka P; Mirchandani I; Goldfarb S
    Cancer; 1981 Nov; 48(9):2047-55. PubMed ID: 6975157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
    Kim H; Nathwani BN; Rappaport H
    Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Terminal deoxynucleotidyl transferase activity in malignant lymphomas.
    Donlon JA; Jaffe ES; Braylan RC
    N Engl J Med; 1977 Sep; 297(9):461-4. PubMed ID: 301987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mediastinal lymphomas].
    Rauthe S; Rosenwald A
    Pathologe; 2016 Sep; 37(5):457-64. PubMed ID: 27507160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leukemic manifestations in a patient with extranodal lymphoma--lymphosarcoma cell leukemia or prolymphocytic leukemia?
    Shimizu K; Ohnishi K; Kunii A
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):118-23. PubMed ID: 3859174
    [No Abstract]   [Full Text] [Related]  

  • 51. Leukemic phase of intermediate non-Hodgkin's lymphoma with cells showing different matured stages in invaded various organs.
    Shimamoto T; Ohyashiki K; Nehashi Y; Tauchi T; Ohyashiki JH; Toyama K
    Intern Med; 1992 Apr; 31(4):553-6. PubMed ID: 1385993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Membrane receptors of lymphoreticular cells in hyperplastic and neoplastic diseases of the lymphatic system].
    Krüger G; Uhlmann C; Hellriegel KP; Sesterhenn K; Samii H; Fischer R; Wustrow F; Gross R
    Hamatol Bluttransfus; 1976; 18():17-29. PubMed ID: 1085715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
    Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
    Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases.
    Osborne BM; Robboy SJ
    Cancer; 1983 Nov; 52(10):1933-43. PubMed ID: 6627208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GIANT FOLLICULAR LYMPH NODE DISEASE. CLINICAL AND PATHOLOGICAL REVIEW OF SIXTY-FOUR CASES.
    FIRAT D; STUTZMAN L; STUDENSKI ER; PICKREN J
    Am J Med; 1965 Aug; 39():252-9. PubMed ID: 14320692
    [No Abstract]   [Full Text] [Related]  

  • 58. Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance.
    Morra E; Lazzarino M; Orlandi E; Pagnucco G; Brusamolino E; Castello A; Inverardi D; Bernasconi C
    Haematologica; 1984; 69(1):15-29. PubMed ID: 6428991
    [No Abstract]   [Full Text] [Related]  

  • 59. High-grade transformation of chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma. Genotypic confirmation of clonal identity.
    Traweek ST; Liu J; Johnson RM; Winberg CD; Rappaport H
    Am J Clin Pathol; 1993 Nov; 100(5):519-26. PubMed ID: 8249891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Tumorous diseases of the lymphatic system (in 2 parts)].
    Hehenwarter W; Huber H
    Acta Med Austriaca; 1977; 4(2):37-44. PubMed ID: 906779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.